Vol 34,2025 No.2 | Articles | Chinese Journal of Pharmacoepidemiology

Home Articles Vol 34,2025 No.2

No.2
No.1

 Contents

Vol 34,2025 No.2

Date of publication: February 15, 2025

 Get cover  Get contents

 Prev
Vol 34,2025 No.1

Revision process of the Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition)

YAN Jinan WU Yunxiao NIE Xiaolu ZHAO Houyu ZHAN Siyan SUN Feng

2025,34(2):121-135

Pharmacoepidemiological research Methodology Guidelines Expert consultation Consensus
Details Download Mobile

Construction and validation of a predictive model for montelukast sodium-related adverse reactions in children with community-acquired pneumonia

SUN Mengmeng ZHU Lin WANG Zongyan ZHOU Bi

2025,34(2):136-143

Montelukast sodium Community-acquired pneumonia Adverse drug reactions Influence factor Prediction model
Details Download Mobile
Penyan pill combined with thunder fire moxibustion in patients with sequelae of pelvic inflammatory disease: a randomized controlled trial

HU Yi YU Yanlan TANG Li

2025,34(2):144-150

Penyan pill Thunder fire moxibustion Sequelae of pelvic inflammatory disease Randomized controlled trial
Details Download Mobile
Retrospective study of diclofenac sodium in combination with tramadol for preemptive analgesia in outpatient menopausal women undergoing IUD removal

WANG Qun ZHANG Qing HUANG Wei

2025,34(2):151-156

Postmenopausal women intrauterine device removal Diclofenac sodium Tramadol Preemptive analgesia
Details Download Mobile
Signals mining and analysis of adverse drug events in minors using recombinant human growth hormone based on the FAERS database

DONG Jiaxiao WANG Yilei LI Xiuzheng LI Jie XU Yichun XU Xiaodong

2025,34(2):157-165

Recombinant human growth hormone Data mining Adverse drug events Minors Pharmacovigilance
Details Download Mobile
Signal mining and analysis of adverse events for lecanemab based on the FAERS database

ZHANG Wen LI Min LIU Erping TAO Wenting CAI Rui ZHOU Weixian

2025,34(2):166-174

Lecanemab FAERS database Drug adverse events Signal mining
Details Download Mobile
Cost-effectiveness analysis of low-dose steriod combined with tacrolimus or cyclophosphamide in the treatment of adult idiopathic membranous nephropathy

GUO Shanshan GUO Li LI Jiandong ZHENG Xijie CHEN Hang

2025,34(2):175-181

Steroid Tacrolimus Idiopathic membranous nephropathy Decision tree model Pharmacoeconomics
Details Download Mobile
Study of the effect of Banxia Xiexin decoction on glucose and lipid metabolism and modulation of pancreatic sweet taste receptor signaling pathway in pre-diabetic rats

ZHOU Liang SONG Xiudao

2025,34(2):182-190

Banxia Xiexin decoction Pre-diabetes Insulin secretion Sweet taste receptor
Details Download Mobile
Safety of disialoganglioside targeted therapies in the treatment of pediatric neuroblastoma: a systematic review and Meta-analysis

XING Ying PANG Yu ZHAN Siyan

2025,34(2):191-204

Disialoganglioside Neuroblastoma Safety Systematic review Meta-analysis
Details Download Mobile

Shandong expert consensus on comprehensive clinical evaluation of sodium-glucose cotransporter 2 inhibitors

ZHAO Quan

2025,34(2):205-215

Sodium-glucose cotransporter 2 inhibitor Comprehensive clinical evaluation Expert consensus
Details Download Mobile

Research progress on the application and safety of botulinum toxin type A during pregnancy

LIU Yanan CHENG Hong

2025,34(2):216-223

Botulinum toxin type A Safety in pregnancy Birth defects Botulinum antitoxin
Details Download Mobile